- recruitingHuman Pharmacology (Phase I)- Other
A Phase 1 open-label positron emission tomography TRIAL to assess changes in liver uptake of [68Ga]Ga-FAPI-46 following oral administration of single doses of AZD2389 to patients with advanced liver fibrosis (PECHORA)
This early-stage study looks at a new experimental medicine called AZD2389 for advanced liver scarring (fibrosis). Researchers use special liver scans to see how a single dose travels through the body and affects active scarring cells. This helps scientists understand if the drug works as intended.
Sweden - recruitingNA
SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population
This study looks at whether regular liver screening using a simple blood test (FIB4) helps find serious liver problems earlier in people aged 18-70. It aims to see if checking everyone who has a high FIB4 result leads to better care.
France